Literature DB >> 22770591

Voice parameters and videonasolaryngoscopy in children with vocal nodules: a longitudinal study, before and after voice therapy.

Victor Valadez1, Antonio Ysunza, Esther Ocharan-Hernandez, Norma Garrido-Bustamante, Araceli Sanchez-Valerio, Ma C Pamplona.   

Abstract

BACKGROUND: Vocal Nodules (VN) are a functional voice disorder associated with voice misuse and abuse in children. There are few reports addressing vocal parameters in children with VN, especially after a period of vocal rehabilitation.
OBJECTIVE: The purpose of this study is to describe measurements of vocal parameters including Fundamental Frequency (FF), Shimmer (S), and Jitter (J), videonasolaryngoscopy examination and clinical perceptual assessment, before and after voice therapy in children with VN. Voice therapy was provided using visual support through Speech-Viewer software.
MATERIALS AND METHODS: Twenty patients with VN were studied. An acoustical analysis of voice was performed and compared with data from subjects from a control group matched by age and gender. Also, clinical perceptual assessment of voice and videonasolaryngoscopy were performed to all patients with VN. After a period of voice therapy, provided with visual support using Speech Viewer-III (SV-III-IBM) software, new acoustical analyses, perceptual assessments and videonasolaryngoscopies were performed.
RESULTS: Before the onset of voice therapy, there was a significant difference (p<0.05) in mean FF, S and J, between the patients with VN and subjects from the control group. After the voice therapy period, a significant improvement (p<0.05) was found in all acoustic voice parameters. Moreover, perceptual voice analysis demonstrated improvement in all cases. Finally, videonasolaryngoscopy demonstrated that vocal nodules were no longer discernible on the vocal folds in any of the cases.
CONCLUSIONS: SV-III software seems to be a safe and reliable method for providing voice therapy in children with VN. Acoustic voice parameters, perceptual data and videonasolaryngoscopy were significantly improved after the speech therapy period was completed.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22770591     DOI: 10.1016/j.ijporl.2012.06.007

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  6 in total

Review 1.  Clinical practice: vocal nodules in dysphonic children.

Authors:  Regina Helena Garcia Martins; Anete Branco; Elaine Lara Mendes Tavares; Andrea Cristina Jóia Gramuglia
Journal:  Eur J Pediatr       Date:  2013-05-31       Impact factor: 3.183

2.  Relative Fundamental Frequency in Children With and Without Vocal Fold Nodules.

Authors:  Elizabeth S Heller Murray; Roxanne K Segina; Geralyn Harvey Woodnorth; Cara E Stepp
Journal:  J Speech Lang Hear Res       Date:  2020-02-14       Impact factor: 2.297

3.  Average Ambulatory Measures of Sound Pressure Level, Fundamental Frequency, and Vocal Dose Do Not Differ Between Adult Females With Phonotraumatic Lesions and Matched Control Subjects.

Authors:  Jarrad H Van Stan; Daryush D Mehta; Steven M Zeitels; James A Burns; Anca M Barbu; Robert E Hillman
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-05-29       Impact factor: 1.547

Review 4.  Impact of Voice Therapy on Pediatric Patients With Dysphonia and Vocal Nodules: A Systematic Review.

Authors:  Mohammad Al-Kadi; Mohamed A Alfawaz; Fahad Z Alotaibi
Journal:  Cureus       Date:  2022-04-24

5.  Vocal nodules in children: Laryngoscopic morphological classification aids prognostic judgment.

Authors:  Jia Liu; Wei Cao; Dan-Hua Sun; Lei Wu; Jing Sun; Bin Xu; Yong Fu
Journal:  Front Pediatr       Date:  2022-09-06       Impact factor: 3.569

6.  Effect of voice training in the voice rehabilitation of patients with vocal cord polyps after surgery.

Authors:  Li Lin; Na Sun; Qiuhua Yang; Ya Zhang; Ji Shen; Lixin Shi; Qin Fang; Guangbin Sun
Journal:  Exp Ther Med       Date:  2014-01-23       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.